4Konishi N,Nakamura M,Nakaoka S,et al.Immunohistochemical analysis of midkine expression in human prostate carcinoma[J].Karger Publiser (Oncology),1999,57 (3):253-257.
5Ikematsu S,Yano A,Aridome K,et al.Serum midkine levels are increased in patients with various types of carcinomas[J].American Cancer Sociaty(Br J Cancer),2000,83 (6):701-706.
6Shimada H,Nabeya Y,Tagawa M,et al.Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma[J].Blackwell Synerrgy (Cancer Sci),2003,94(7):628-632.
8Ikematsu S,Okamoto K,Yoshida Y,et al.High levels of urinary midkine in various cancer patients[J].Elsevier Publiser (Biochem.Biophys.Res.Commun.),2003,306(2):329-332.
9Dai L,Xu D,Yao X,et al.Conformational determinants of the intracellular localization of midkine,Elsevier Publiser (Biochem.Biophys.Res.Commun.),2005,330(1):310-317.
10Stoica G,Kuo A,Powers C,et al.Midkine Binds to Anaplastic Lymphoma Kinase (ALK) and Acts as a Growth Factor for Different Cell Types[J].ASBMB (Biological Chemistry),2002,277(39):35990-35998.
二级参考文献24
1Zhang N，Curr Opin Hematol，1999年，6卷，1期，44页
2Ye C，J Cancer，1999年，79卷，1期，179页
3盛继群，复旦学报，1998年，37卷，4期，413页
4章静波，细胞生物学实用方法与技术，1995年
5O'Brien T, Cranston D, Fuggle S, et al. The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers [J].Cancer Res, 1996, 56 (11):2515～2518
6Konishi N, Nakamura M, Nakaoka S, et al. Immunohistochemical analysis of midkine expression in human prostate carcinoma [J].Oncology, 1999, 57(3):253-257
7Ikematsu S, Yano A, Aridome K, et al. Serum midkine levels are increased in patients with various types of carcinomas [J]. Br J Cancer, 2000, 83(6):701-706
8Kato M, Shinozawa T, Kato S, et al. Increased midkine expression in hepatocellular carcinoma [J]. Arch Pathol Lab Med, 2000,124(6) :848-852
9Funaki NO, Tanaka J, Seto SI, et al. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver[J]. Hepatology, 1997, 25(3):564-568
10Jiang SY, Shyu RY, Huang MF, et al. Detection of alphafetoprotein-expressing cells in the blood of patients with hepatoma and hepatitis[J]. BrJ cancer, 1997,75(6):928-933
4Ogawa K,Ito Y,Hirokawa N,et al.Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma:impact of adjuvant chemotherapy on survival[J].Int J Radiation Oncol Biol Phys,2012,83(2):559-565.
5Ota T,Ota K,Jono H,et al.Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis[J].Oral Oncology,2010,46(9):657-661.
6Huang Y,Sook-Kim M,Ratovitski E.Midkine promotes tetraspanin-integrin interaction and induces FAK-Stat1α pathway contributing to migration/invasiveness of human head and neck squamous cell carcinoma cells[J].BBRC,2008,377(2):474-478.
7Salama R H,Muramatsu H,Zou P,et al.Midkine,a heparin-binding growth factor,produced by the host enhances metastasis of Lewis lung carcinoma cells[J].Cancer Lett,2006,233(1):16-20.
8Krzystek-Korpacka M,Matusiewicz M,Diakowska D,et al.Impact of weight loss on circulating IL-1,IL-6,IL-8,TNF-α,VEGF-A,VEGF-C and midkine in gastroesophageal cancer patients[J].Clin Biochem,2007,40(18):1353-1360.
9Xu Y,Qu X,Zhang X,et al.Midkine positively regulates the proliferation of human gastric cancer cells[J].Cancer Lett,2009,279(2):137-144.
10Rawnaq T,Kunkel M,Simon R,et al.Serum midkine correlates with tumor progression and imatinib in gastrointestinal stromal tumors[J].J Surg Res,2010,158(2):188.
